Establishing of Cancer Mission Hubs: Networks and Synergies

HealthHORIZON-CSAID: 101104587
EC Contribution
โ‚ฌ60,961
Consortium Size
64 orgs
Start Year
2023
โ–ถSummary

Cancer- healthcare, research and innovation face core common challenges, such as fragmentation of initiatives and distancing from important stakeholders, requiring coordinated solutions. These challenges are recognized in Horizon Europeโ€™s Cancer Mission Implementation Plan and in Europeโ€™s Beating Cancer Plan. The proposal Establishing of Cancer Mission Hubs: Networks and Synergies (ECHoS) represents a unique opportunity to coordinate R&I and Healthcare actions on cancer with policy-making processes creating transnational communication & collaboration networks aligned with Cancer Mission objectives. Experiences shows that the setup and implementation of innovative health solutions are more likely to be successful when a broad range of stakeholders and decision-makers from the public and private sectors are part of the process. By fostering the creation of National Cancer Mission Hubs (NCMHs) in member states and associated countries ECHoS will create the conditions for organized stakeholders and individual citizens to collaborate and engage in policy dialogues. The implementation of the Cancer Mission objectives will promote more resilient and people-centric healthcare and research systems.ECHoS will produce (i) general models and guidelines for the creation of sustainable NCMHs, (ii) a knowledge exchange programme to support development of NCMHs competences, (iii) impact models and training sets to help efficiently engaging with distinct stakeholders, (iv) a toolkit for synergies to help NCMH engaging in collaborative work with individual European Initiatives, (v) a business continuity model envisaging long-term sustainability of a EU network of NCMHs and (vi) a calendar of events to create awareness on NCMHs and to help closing the gap in citizensโ€™ participation in cancer policy. In summary, ECHoS will create conditions for NCMHs to be Mission Cancer advocates in MS/AC and set the pace for the development of a transnational network of NCMHs in a second phase.

Consortium (64)

๐Ÿ‡ต๐Ÿ‡น AICIB - AGENCIA DE INVESTIGACAO CLINICA E INOVACAO BIOMEDICAPT
coordinator
๐Ÿ‡ฎ๐Ÿ‡น ALLEANZA CONTRO IL CANCROIT
partner
๐Ÿ‡ท๐Ÿ‡ด ASOCIATIA CENTRUL PENTRU INOVATIE IN MEDICINARO
partner
๐Ÿ‡ฑ๐Ÿ‡ป Augstakas izglitibas un zinatnes informacijas tehnologijas koplietosanas pakalpojumu centrsLV
partner
๐Ÿ‡ง๐Ÿ‡ฌ BALGARSKI KLASTER ZA DIGITALNIRESHENIA I INOVATSIIV ZDRAVEOPAZVABG
partner
๐Ÿ‡จ๐Ÿ‡พ CYPRUS CANCER RESEARCH INSTITUTECY
partner
๐Ÿ‡ฉ๐Ÿ‡ช DEUTSCHES ZENTRUM FUR LUFT - UND RAUMFAHRT EVDE
partner
๐Ÿ‡ฌ๐Ÿ‡ท ETHNIKO KENTRO TEKMIRIOSIS KAI ILEKTRONIKOU PERIECHOMENOUGR
partner
๐Ÿ‡ง๐Ÿ‡ช EUROPEAN CANCER ORGANISATIONBE
partner
๐Ÿ‡จ๐Ÿ‡ฟ FAKULTNI NEMOCNICE BRNOCZ
partner
๐Ÿ‡จ๐Ÿ‡ฟ FAKULTNI NEMOCNICE OLOMOUCCZ
partner
๐Ÿ‡จ๐Ÿ‡ฟ FAKULTNI NEMOCNICE U SV ANNY V BRNECZ
partner
๐Ÿ‡ฎ๐Ÿ‡น FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORIIT
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACION TECNALIA RESEARCH & INNOVATIONES
partner
๐Ÿ‡ฆ๐Ÿ‡น GESUNDHEIT OSTERREICH GMBHAT
partner
๐Ÿ‡ฎ๐Ÿ‡ช HEALTH SERVICE EXECUTIVEIE
partner
๐Ÿ‡ซ๐Ÿ‡ฎ HUS-YHTYMAFI
partner
๐Ÿ‡ฑ๐Ÿ‡บ INSTITUT NATIONAL DU CANCERLU
partner
๐Ÿ‡ซ๐Ÿ‡ท INSTITUT NATIONAL DU CANCER GIPFR
partner
๐Ÿ‡ช๐Ÿ‡ธ INSTITUTO DE SALUD CARLOS IIIES
partner
๐Ÿ‡ธ๐Ÿ‡ช KAROLINSKA INSTITUTETSE
partner
๐Ÿ‡ฑ๐Ÿ‡น KLAIPEDOS UNIVERSITETASLT
partner
๐Ÿ‡ญ๐Ÿ‡ท KLINICKI BOLNICKI CENTAR SESTRE MILOSRDNICE USTANOVAHR
partner
๐Ÿ‡ณ๐Ÿ‡ด KREFTFORENINGENNO
partner
๐Ÿ‡ฑ๐Ÿ‡ป LATVIJAS ZINATNES PADOMELV
partner
๐Ÿ‡ฑ๐Ÿ‡น Lietuvos mokslo tarybaLT
partner
๐Ÿ‡ฑ๐Ÿ‡น LIETUVOS SVEIKATOS MOKSLU UNIVERSITETASLT
partner
๐Ÿ‡ฑ๐Ÿ‡น LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOSLT
partner
๐Ÿ‡ฑ๐Ÿ‡บ LUXEMBOURG INSTITUTE OF HEALTHLU
partner
๐Ÿ‡ต๐Ÿ‡น MINISTERIO DA SAUDEPT
partner
๐Ÿ‡ฒ๐Ÿ‡น MINISTERU GHALL-EDUKAZZJONI, L-ISPORT, IZ-ZGHAZAGH, IR-RICERKA U L-INNOVAZZJONIMT
partner
๐Ÿ‡ฒ๐Ÿ‡น MINISTERU GHAS-SAHHA U L-ANZJANITA ATTIVAMT
partner
๐Ÿ‡ฎ๐Ÿ‡ฑ MINISTRY OF HEALTHIL
partner
๐Ÿ‡บ๐Ÿ‡ฌ MINISTRY OF HEALTHUG
partner
๐Ÿ‡ฑ๐Ÿ‡น NACIONALINIS VEZIO INSTITUTASLT
partner
๐Ÿ‡ธ๐Ÿ‡ฎ NACIONALNI INSTITUT ZA JAVNO ZDRAVJESI
partner
๐Ÿ‡ธ๐Ÿ‡ฐ NADACIA VYSKUM RAKOVINYSK
partner
๐Ÿ‡ธ๐Ÿ‡ฐ NARODNY ONKOLOGICKY USTAVSK
partner
๐Ÿ‡ต๐Ÿ‡ฑ NARODOWE CENTRUM BADAN I ROZWOJUPL
partner
๐Ÿ‡ต๐Ÿ‡ฑ NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE -PANSTWOWY INSTYTUT BADAWCZYPL
partner
๐Ÿ‡ณ๐Ÿ‡ด NORGES FORSKNINGSRADNO
partner
๐Ÿ‡ญ๐Ÿ‡บ Orszagos Onkologiai IntezetHU
partner
๐Ÿ‡ณ๐Ÿ‡ด OSLO CANCER CLUSTER SANO
partner
๐Ÿ‡ณ๐Ÿ‡ด OSLO UNIVERSITETSSYKEHUS HFNO
partner
๐Ÿ‡ธ๐Ÿ‡ช REGION STOCKHOLMSE
partner
๐Ÿ‡ฉ๐Ÿ‡ฐ REGION SYDDANMARKDK
partner
๐Ÿ‡ฑ๐Ÿ‡ป RIGAS AUSTRUMU KLINISKA UNIVERSITATES SLIMNICA SIALV
partner
๐Ÿ‡ง๐Ÿ‡ฌ SAVMESTNA ONKOLOGICHNA NATSIONALNA MREZHABG
partner
๐Ÿ‡ง๐Ÿ‡ช SCIENSANOBE
partner
๐Ÿ‡ช๐Ÿ‡ช SIHTASUTUS TARTU ULIKOOLI KLIINIKUMEE
partner
๐Ÿ‡ณ๐Ÿ‡ด SINTEF ASNO
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING INTEGRAAL KANKERCENTRUM NEDERLANDNL
partner
๐Ÿ‡ธ๐Ÿ‡ช STIFTELSEN STOCKHOLM SCHOOL OF ECONOMICS (SSE) INSTITUTE FOR RESEARCHSE
partner
๐Ÿ‡ซ๐Ÿ‡ฎ SUOMEN SYOPAYHDISTYS -CANCERFORENINGEN I FINLAND RY - CANCER SOCIETY OF FINLAND CSFFI
partner
๐Ÿ‡ธ๐Ÿ‡ช SVERIGES KOMMUNER OCH REGIONERSE
partner
๐Ÿ‡ช๐Ÿ‡ช TARTU ULIKOOLEE
partner
๐Ÿ‡ง๐Ÿ‡ฌ TSENTAR PO EVROPEYSKI ZDRAVNI POLITIKIBG
partner
๐Ÿ‡น๐Ÿ‡ท TURKIYE SAGLIK ENSTITULERI BASKANLIGITR
partner
๐Ÿ‡ฎ๐Ÿ‡น UNIVERSITA CATTOLICA DEL SACRO CUOREIT
partner
๐Ÿ‡ฎ๐Ÿ‡ช UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINIE
partner
๐Ÿ‡จ๐Ÿ‡ฟ USTAV HEMATOLOGIE A KREVNI TRANSFUZE PRAHACZ
partner
๐Ÿ‡ฑ๐Ÿ‡น VILNIAUS UNIVERSITETASLT
partner
๐Ÿ‡ฑ๐Ÿ‡น VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOSLT
partner
๐Ÿ‡ฒ๐Ÿ‡น XJENZA MALTAMT
partner